Skip to content
A.K. Pharma
Home
Products
About
Blogs
Contact
Home
Products
About
Blogs
Contact
A.K. Pharma
Durvalumab
Imfinzi® (Durvalumab)
Durvalumab 120mg/2.4mL, 500mg/10mL Injection — Anti-PD-L1 Checkpoint Inhibitor for Unresectable Stage III NSCLC, Extensive-Stage SCLC, Biliary Tract Cancer and Hepatocellular Carcinoma
Request Quote
Menu
Home
Products
About
Blogs
Contact
Quote Request Form
Name
Email
Phone
Message
Ask for quote!
Quote Request Form
Name
Email
Phone
Message
Let's get started!
